PRIMED AAMI Level 3 Open Back Gowns
PRIMED Medical Products, Inc. · Decision date Sep 11, 2026
What did the FDA decide?
PRIMED Medical Products, Inc. received a substantially equivalent (SESE) decision for PRIMED AAMI Level 3 Open Back Gowns under 510(k) K262007, with a decision date of September 11, 2026. The application was received June 15, 2026 and reviewed under regulation 878.4040, product code QPC, in the General and Plastic Surgery specialty. SESE in this context is a 510(k) clearance, not a PMA approval.
The FDA summary describes the gowns as non-sterile, single-use gowns intended to be worn by healthcare personnel to protect both the patient and the wearer. The record lists the review as traditional, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The summary does not state a predicate device, performance testing results, or the specific barrier test data behind the AAMI Level 3 designation; those details would need to be confirmed in the full FDA documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262007
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- PRIMED Medical Products, Inc.
- Product code
- QPC
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Gown, Non-Sterile, Non-Isolation, Intended To Provide Moderate Or High Barrier Protection.
- Applicant
- PRIMED Medical Products, Inc.
- Product code
- QPC
- FDA device class
- 2
FDA decision timeline
K262007 received
Application receipt date recorded by FDA.
K262007 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QPC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Stryker Instruments | 510(k) clearance | Nov 4, 2026 | FDA | |
| PolyConversions, Inc. | 510(k) clearance | Aug 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
PRIMED Medical Products, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Edmonton
Sources and methodology
- Original FDA record: K262007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
